CompoAtlas

Karden

Natural health product licensed in Canada

Other names
Cardio-Régulateur
Licence holder
Groupe E.N. biomédical Inc.
NPN or DIN-HM
80082298
Status
Active licence
Licence date
10 January 2018
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Crataegus monogyna

Source : Fleurs et feuilles

Extraction ratio : 5.333:1

Dry plant equivalent : 800 milligramme

Potency : 2.2 % Flavonoïdes comme l'hypéroside

150 milligrammeNot calculated
Magnésium

Source : Citrate de magnésium

50 milligramme300,000 µg

Non-medicinal ingredients

Fleur d'Hibiscus sabdariffa, Gélatine

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsuleminimum: 1 day ; maximum: 3 days

Uses authorised in Canada

Utilisé en phytothérapie/herboristerie pour aider au maintien et/ou au soutien de la santé cardiovasculaire chez les adultes. Aide l'organisme à métaboliser les glucides (hydrates de carbone). Aide l'organisme à métaboliser les protéines. Aide l'organisme à métaboliser les lipides. Aide au développement et au maintien des os. Aide au développement et au maintien des dents. Aide à la formation des tissus. Aide au bon fonctionnement des muscles.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80082298

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line